# OrthoAccel Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orthoaccel-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Bellaire, US
- Website: www.acceledent.com
- Total disclosed funding: $24M
- Latest round: Series C (May 4, 2016)
- Investors on record: 3

## About

OrthoAccel Technologies, Inc. is a medical technology firm specializing in innovative orthodontic solutions designed to enhance treatment efficiency and patient comfort through its distinct offerings.OrthoAccel Technologies, Inc. was founded in 2007 and is headquartered in Bellaire, US. The company focuses on providing advanced orthodontic devices and has successfully raised USD 12 mn in Series C financing in May 2016 from investors such as HealthPointCapital, Piper Jaffray, and S3 Ventures. The firm has engaged in a total of 8 deals since its inception.OrthoAccel Technologies, Inc. markets the premium domain name AccEleDent.com, targeting businesses in the dental and healthcare sectors to bolster their online branding. This digital asset serves as a memorable web address, aiding companies in enhancing their search engine visibility and customer attraction. The firm offers high-value domain names aimed at dental practices, health services, and related sectors, catering to small to medium-sized enterprises, startups, and established companies across North America, Europe, and Asia.The revenue model for OrthoAccel Technologies, Inc. is primarily based on the sale of premium domain names, with AccEleDent.com priced at USD 17,199. The purchasing process is straightforward, offering buyers options for full upfront payment or a flexible payment plan. This model not only facilitates ownership accessibility but also generates revenue directly from domain sales, with potential additional income from ancillary services such as logo creation. Transactions are secured to ensure trust, with funds released to the seller only after the buyer confirms receipt of the domain.In May 2016, OrthoAccel Technologies, Inc. raised USD 12 mn in Series C financing, which will support the development of new orthodontic products and expansion into untapped markets. The firm aims to broaden its reach within North America and enter new territories in Europe and Asia by the end of 2023. This strategic growth plan focuses on leveraging recent funding to fuel innovation and increase market presence.

## Funding rounds

- Series C, May 4, 2016, $12M — HealthPointCapital, S3 Ventures, Piper Sandler
- Series B, Apr 30, 2012, $11M — HealthPointCapital, S3 Ventures
- Series A, Aug 25, 2008, $0.5M — S3 Ventures

## Investors

- S3 Ventures (https://capitalatlas.ai/funds/s3-ventures) — Series A, Series B, Series C
- HealthPointCapital (https://capitalatlas.ai/funds/healthpointcapital) — Series B, Series C
- Piper Sandler (https://capitalatlas.ai/funds/piper-sandler) — Series C